November 22, 2022: ANCA-associated vasculitis Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare disease, but many incidences of relapse or new-onset cases were documented after COVID-19 vaccination.
November 18, 2022: Vitiligo days after vaccination Multiple cases have been reported for individuals with and without family history.
November 17, 2022: Olfactory Signatures and COVID-19 Olfactory disorders have a significant impact on human lives. A new peer-reviewed paper compared sufferers of related disorders to general populations in respect to their response to COVID-19 vaccines and SARS-Co-V2 infections.
November 16, 2022: Rapidly Progressive Dementia Following COVID-19 Vaccination A previously healthy woman in her 60s develops rapidly progressing neuropsychiatric problems after ChAdOx1 nCoV-19 vaccination.
November 9, 2022: Genetic predisposition to Long-COVID-like symptoms A case is presented when COVID-19-vaccine induced long-COVID-like symptoms and so did subsequent breakthrough COVID-19.
November 4, 2022: Vaccines and Infections Personalized, precise and predictive vaccinology's holy grail is to anticipate immune response for every individual.
November 4, 2022: The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups The findings of this peer-reviewed research demonstrate that vaccine adverse reactions in older individuals are being overlooked, and the incidence of VAEs impairing immunity may be higher than previously perceived.
November 3, 2022: Hemophagocytic Lymphohistiocytosis after Vaccination A case of a life-threatening disorder characterized by unbridled activation of cytotoxic T lymphocytes, natural killer (NK) cells, and macrophages.
November 18, 2022: Vitiligo days after vaccination Multiple cases have been reported for individuals with and without family history.
November 17, 2022: Olfactory Signatures and COVID-19 Olfactory disorders have a significant impact on human lives. A new peer-reviewed paper compared sufferers of related disorders to general populations in respect to their response to COVID-19 vaccines and SARS-Co-V2 infections.
November 16, 2022: Rapidly Progressive Dementia Following COVID-19 Vaccination A previously healthy woman in her 60s develops rapidly progressing neuropsychiatric problems after ChAdOx1 nCoV-19 vaccination.
November 9, 2022: Genetic predisposition to Long-COVID-like symptoms A case is presented when COVID-19-vaccine induced long-COVID-like symptoms and so did subsequent breakthrough COVID-19.
November 4, 2022: Vaccines and Infections Personalized, precise and predictive vaccinology's holy grail is to anticipate immune response for every individual.
November 4, 2022: The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups The findings of this peer-reviewed research demonstrate that vaccine adverse reactions in older individuals are being overlooked, and the incidence of VAEs impairing immunity may be higher than previously perceived.
November 3, 2022: Hemophagocytic Lymphohistiocytosis after Vaccination A case of a life-threatening disorder characterized by unbridled activation of cytotoxic T lymphocytes, natural killer (NK) cells, and macrophages.
RSS Feed
